ESOPAug 13, 2026, 06:07 AM
OnKure Reprices 1.7M Underwater Stock Options to $4.14
AI Summary
OnKure Therapeutics, Inc. announced its Board of Directors approved the repricing of approximately 1.7 million underwater stock options on August 7, 2026. The repricing applies to options granted before January 1, 2025, with original exercise prices of $10.00 or more, setting the new exercise price at $4.14, the closing price on the effective date. This action, affecting employees and consultants including named executive officers, aims to provide retention and performance incentives without incurring significant stock dilution or cash expenditures, though a retention requirement applies.
Key Highlights
- Board approved repricing of approximately 1.7 million underwater stock options.
- New exercise price set at $4.14 per share, the closing price on August 7, 2026.
- Original exercise prices for repriced options ranged from $13.99 to $24.59 per share.
- Options with an original exercise price of $10.00 or greater were eligible for repricing.
- CEO Nicholas Saccomano had 571,423 shares of eligible options repriced.
- CMO Samuel Agresta had 149,984 shares of eligible options repriced.
- CFO Jason Leverone had 141,714 shares of eligible options repriced.
- Approximately 40% of outstanding stock options were eligible for repricing.
Price Impact
More from OKUR